CoChat

Genetic Variant Showing a Positive Interaction With β-Blocking Agents With a Beneficial Influence on Lipoprotein Lipase Activity, HDL Cholesterol, and Triglyceride Levels in Coronary Artery Disease Patients: The Ser 447 -Stop Substitution in the Lipoprotein Lipase Gene

Groenemeijer, Björn E., Hallman, Michael D., Reymer, Paul W.A., Gagné, Eric, Kuivenhoven, Jan Albert, Bruin, Taco, Jansen, Hans, Lie, Kong I., Bruschke, Albert V.G., Boerwinkle, Eric, Hayden, Michael R., Kastelein, John J.P. · 1997 · Circulation
Cited by 137

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Background Lipoprotein lipase (LPL) is the rate-limiting enzyme in the lipolysis of triglyceride-rich lipoproteins, and the gene coding for LPL is therefore a candidate gene in atherogenesis. We previously demonstrated that two amino acid substitutions in LPL, the Asn 291 -Ser and the Asp 9 -Asn, are associated with elevated triglycerides and lower HDL cholesterol and are present with greater frequency in coronary artery disease (CAD) patients than in normolipidemic control subjects. Conversely, a third frequent mutation in this gene, the Ser 447 -Stop, is reported by some investigators to underlie higher HDL cholesterol levels and would represent a beneficial genetic variant in lipoprotein metabolism. We therefore sought conclusive evidence for these allegations by investigating the effects of the LPL Ser 447 -Stop mutation on LPL and hepatic lipase (HL) activity, HDL cholesterol, and triglycerides in a large group of CAD patients (n=820) with normal to mildly elevated total and LDL cholesterol levels. Methods and Results Carriers of the Ser 447 -Stop allele (heterozygotes and homozygotes) had significantly higher postheparin LPL activity ( P =.034), normal postheparin HL activity ( P =.453), higher HDL cholesterol levels ( P =.013), and lower triglyceride levels ( P =.044) than noncarriers. The influence of the Ser 447 -Stop allele on LPL activity was pronounced in patients using β-blockers ( P =.042) and not significant in those not using them ( P =.881), suggesting a gene-environment interaction between the Ser 447 -Stop mutation and β-blockers. Conclusions We conclude that the LPL Ser 447 -Stop mutation has a significant positive effect on LPL activity and HDL cholesterol and triglyceride levels and that certain subgroups of CAD patients carrying the Ser 447 -Stop mutation will have less adverse metabolic effects when placed on β-blockers. The LPL Ser 447 -Stop mutation therefore should have a protective effect against the development of atherosclerosis and subsequent CAD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.95.12.2628

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 137

Metadata

Authors
Groenemeijer, B. E., Hallman, M. D., Reymer, P. W. A., Gagné, E., Kuivenhoven, J. A., Bruin, T., Jansen, H., Lie, K. I., Bruschke, A. V. G., Boerwinkle, E., Hayden, M. R., & Kastelein, J. J. P.
Venue
Circulation
Published
1997-06-17
Volume
95
Issue
12
Pages
2628-2635
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2013264580
Cited by
137
References
1
FWCI
5.35
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic Variant Showing a Positive Interaction With β-Blocking Agents With a Beneficial Influence on Lipoprotein Lipase Activity, HDL Cholesterol, and Triglyceride Levels in Coronary Artery Disease Patients: The Ser 447 -Stop Substitution in the Lipoprotein Lipase Gene. https://app.cochat.ai/papers/10.1161/01.cir.95.12.2628
The paper
Groenemeijer, B. E., Hallman, M. D., Reymer, P. W. A., Gagné, E., Kuivenhoven, J. A., Bruin, T., Jansen, H., Lie, K. I., Bruschke, A. V. G., Boerwinkle, E., Hayden, M. R., & Kastelein, J. J. P. (1997). Genetic Variant Showing a Positive Interaction With β-Blocking Agents With a Beneficial Influence on Lipoprotein Lipase Activity, HDL Cholesterol, and Triglyceride Levels in Coronary Artery Disease Patients: The Ser 447 -Stop Substitution in the Lipoprotein Lipase Gene. Circulation. https://doi.org/10.1161/01.cir.95.12.2628

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.